HOOKIPA Pharma Inc
NASDAQ:HOOK
Cash Flow Statement
Cash Flow Statement
HOOKIPA Pharma Inc
| Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||||||
| Net Income |
(5)
|
(11)
|
(18)
|
(43)
|
(45)
|
(40)
|
(42)
|
(44)
|
(50)
|
(60)
|
(67)
|
(76)
|
(76)
|
(76)
|
(74)
|
(65)
|
(67)
|
(68)
|
(69)
|
(82)
|
(48)
|
(49)
|
(43)
|
(44)
|
(73)
|
|
| Depreciation & Amortization |
0
|
1
|
2
|
1
|
1
|
1
|
1
|
4
|
5
|
6
|
6
|
5
|
5
|
4
|
4
|
4
|
3
|
3
|
3
|
4
|
3
|
3
|
3
|
3
|
3
|
|
| Stock-Based Compensation |
0
|
1
|
3
|
6
|
7
|
8
|
9
|
9
|
8
|
9
|
8
|
8
|
8
|
6
|
6
|
5
|
4
|
3
|
3
|
2
|
1
|
1
|
2
|
2
|
0
|
|
| Other Non-Cash Items |
0
|
1
|
3
|
7
|
9
|
11
|
12
|
9
|
8
|
8
|
7
|
9
|
9
|
8
|
7
|
5
|
4
|
3
|
3
|
15
|
14
|
14
|
15
|
6
|
6
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(3)
|
(13)
|
(10)
|
(7)
|
(3)
|
(8)
|
(7)
|
(8)
|
(9)
|
(10)
|
(10)
|
(4)
|
13
|
16
|
17
|
36
|
34
|
36
|
30
|
5
|
(49)
|
(42)
|
(42)
|
(42)
|
12
|
|
| Cash from Operating Activities |
(7)
N/A
|
(22)
-210%
|
(24)
-11%
|
(42)
-72%
|
(37)
+12%
|
(36)
+2%
|
(37)
-2%
|
(39)
-7%
|
(47)
-18%
|
(57)
-22%
|
(64)
-13%
|
(66)
-3%
|
(50)
+24%
|
(48)
+5%
|
(46)
+2%
|
(20)
+57%
|
(25)
-23%
|
(26)
-4%
|
(33)
-30%
|
(58)
-73%
|
(79)
-37%
|
(74)
+6%
|
(67)
+9%
|
(77)
-14%
|
(53)
+31%
|
|
| Investing Cash Flow | ||||||||||||||||||||||||||
| Capital Expenditures |
(0)
|
1
|
1
|
(2)
|
(2)
|
(3)
|
(3)
|
(2)
|
(3)
|
(6)
|
(8)
|
(13)
|
(14)
|
(11)
|
(10)
|
(5)
|
(3)
|
(2)
|
(4)
|
(4)
|
(4)
|
(4)
|
(1)
|
(0)
|
(0)
|
|
| Cash from Investing Activities |
(0)
N/A
|
1
N/A
|
1
-8%
|
(2)
N/A
|
(2)
+10%
|
(3)
-47%
|
(3)
-10%
|
(2)
+19%
|
(3)
-5%
|
(6)
-143%
|
(8)
-31%
|
(13)
-58%
|
(14)
-12%
|
(11)
+21%
|
(10)
+14%
|
(5)
+47%
|
(3)
+31%
|
(2)
+34%
|
(4)
-90%
|
(4)
+4%
|
(4)
+4%
|
(4)
+10%
|
(1)
+83%
|
(0)
+68%
|
(0)
+49%
|
|
| Financing Cash Flow | ||||||||||||||||||||||||||
| Net Issuance of Common Stock |
31
|
106
|
106
|
112
|
75
|
(1)
|
0
|
75
|
75
|
75
|
75
|
0
|
75
|
75
|
75
|
75
|
0
|
47
|
46
|
68
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
|
| Other |
(1)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
|
| Cash from Financing Activities |
28
N/A
|
104
+269%
|
104
-1%
|
110
+6%
|
73
-33%
|
(3)
N/A
|
(3)
+11%
|
73
N/A
|
75
+2%
|
75
+0%
|
75
+0%
|
(0)
N/A
|
75
N/A
|
72
-4%
|
72
+0%
|
72
+0%
|
(4)
N/A
|
45
N/A
|
44
-2%
|
66
+49%
|
66
+1%
|
19
-71%
|
20
+3%
|
(1)
N/A
|
(1)
+11%
|
|
| Change in Cash | ||||||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
(3)
|
1
|
1
|
(1)
|
(0)
|
(0)
|
1
|
(2)
|
(2)
|
(3)
|
(3)
|
3
|
3
|
3
|
2
|
(1)
|
0
|
(0)
|
1
|
0
|
(0)
|
(0)
|
(0)
|
1
|
2
|
|
| Net Change in Cash |
19
N/A
|
85
+357%
|
81
-4%
|
65
-20%
|
34
-47%
|
(42)
N/A
|
(42)
+0%
|
30
N/A
|
23
-21%
|
10
-58%
|
0
-95%
|
(76)
N/A
|
14
N/A
|
16
+16%
|
18
+13%
|
47
+159%
|
(32)
N/A
|
17
N/A
|
7
-57%
|
4
-45%
|
(17)
N/A
|
(59)
-244%
|
(48)
+18%
|
(78)
-61%
|
(52)
+32%
|
|
| Free Cash Flow | ||||||||||||||||||||||||||
| Free Cash Flow |
(7)
N/A
|
(21)
-190%
|
(23)
-11%
|
(44)
-87%
|
(39)
+12%
|
(39)
N/A
|
(40)
-3%
|
(42)
-5%
|
(49)
-18%
|
(63)
-28%
|
(72)
-15%
|
(79)
-9%
|
(64)
+19%
|
(59)
+8%
|
(56)
+5%
|
(25)
+55%
|
(28)
-12%
|
(28)
+1%
|
(38)
-35%
|
(62)
-64%
|
(83)
-34%
|
(77)
+6%
|
(68)
+12%
|
(77)
-14%
|
(53)
+31%
|
|